PT Bank BTPN Syariah Tbk (IDX:BTPS)

Ligand Pharmaceuticals Balance Sheet

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,540,496	2,975,056	3,597,272	3,449,564	2,850,760	1,821,834
Investment Securities	8,227,353	7,771,715	5,816,244	5,174,905	4,643,203	4,719,951
Total Investments	8,227,353	7,771,715	5,816,244	5,174,905	4,643,203	4,719,951
Gross Loans	12,325,151	12,491,515	14,164,569	14,358,226	12,990,248	11,856,944
Allowance for Loan Losses	-884,515	-924,274	-1,213,916	-768,925	-699,265	-849,490
Other Adjustments to Gross Loans	-2,180,343	-2,319,756	-2,776,708	-2,830,763	-2,546,779	-2,334,078
Net Loans	9,260,293	9,247,485	10,173,945	10,758,538	9,744,204	8,673,376
Property, Plant & Equipment	301,339	335,055	376,242	378,767	376,934	332,116
Other Intangible Assets	202,380	212,953	210,744	170,612	129,492	102,308
Accrued Interest Receivable	261,674	249,534	240,402	203,717	165,525	157,724
Restricted Cash	506,838	669,329	663,443	694,427	415,438	378,471
Other Current Assets	97,746	54,022	64,032	167,953	52,710	46,410
Long-Term Deferred Tax Assets	206,723	226,709	273,592	160,622	154,560	196,487
Other Long-Term Assets	7,867	5,722	19,450	2,871	11,030	6,328
Total Assets	21,658,909	21,747,580	21,435,366	21,161,976	18,543,856	16,435,005
Accrued Expenses	286,544	294,863	307,530	309,384	265,769	264,313
Interest Bearing Deposits	11,460,508	11,724,433	12,142,817	12,048,529	10,973,460	9,780,481
Total Deposits	11,460,508	11,724,433	12,142,817	12,048,529	10,973,460	9,780,481
Short-Term Borrowings	-	200,000	-	100,000	-	200,000
Current Portion of Leases	12,985	5,965	2,118	-	-	-
Current Income Taxes Payable	33,765	17,409	34,851	44,342	44,478	107,265
Other Current Liabilities	36,459	41,788	51,296	57,424	36,980	66,172
Long-Term Leases	4,646	19,333	51,674	67,746	80,608	92,939
Pension & Post-Retirement Benefits	88,560	87,260	42,020	20,947	33,338	36,704
Other Long-Term Liabilities	40,189	39,935	25,927	105,609	14,323	8,382
Total Liabilities	11,963,656	12,430,986	12,658,233	12,753,981	11,448,956	10,556,256
Common Stock	770,370	770,370	770,370	770,370	770,370	770,370
Additional Paid-In Capital	846,440	846,440	846,440	846,440	846,440	846,440
Retained Earnings	8,044,842	7,666,787	7,136,434	6,769,100	5,460,588	4,245,485
Treasury Stock	-3,656	-4,320	-5,538	-7,173	-8,941	-9,763
Comprehensive Income & Other	34,228	34,304	26,298	26,218	26,243	26,217
Total Common Equity	9,692,224	9,313,581	8,774,004	8,404,955	7,094,700	5,878,749
Minority Interest	3,029	3,013	3,129	3,040	200	-
Shareholders' Equity	9,695,253	9,316,594	8,777,133	8,407,995	7,094,900	5,878,749
Total Liabilities & Equity	21,658,909	21,747,580	21,435,366	21,161,976	18,543,856	16,435,005
Total Debt	17,631	225,298	53,792	167,746	80,608	292,939
Net Cash (Debt)	2,522,865	2,749,758	3,543,480	3,281,818	2,770,152	1,528,895
Net Cash Growth	48.31%	-22.40%	7.97%	18.47%	81.19%	0.52%
Net Cash Per Share	327.49	356.95	460.01	426.08	359.69	198.53
Filing Date Shares Outstanding	7,704	7,703	7,703	7,702	7,702	7,701
Total Common Shares Outstanding	7,704	7,703	7,703	7,702	7,702	7,701
Book Value Per Share	1258.13	1209.01	1139.02	1091.21	921.20	763.35
Tangible Book Value	9,489,844	9,100,628	8,563,260	8,234,343	6,965,208	5,776,441
Tangible Book Value Per Share	1231.86	1181.37	1111.67	1069.06	904.38	750.07

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.